Albumin Replacement Therapy in Septic Shock
In Sepsis
Wed, 4 Mar 2026
The Albumin Replacement Therapy in Septic Shock (ARISS) trial, published in JAMA Network Open was designed to determine whether albumin replacement improves survival in patients with septic shock. The study was conducted on behalf of the SepNet Critical Care Trials Group and ARISS investigators.
Albumin is a natural colloid with physiological roles extending be...
阅读全文